These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34792764)

  • 1. Endocannabinoid System Attenuates Oxaliplatin-Induced Peripheral Sensory Neuropathy Through the Activation of CB1 Receptors.
    Pereira AF; Lisboa MRP; de Freitas Alves BW; da Silva CMP; Dias DBS; de Menezes KLS; Cesário FRAS; de França JC; de Oliveira AR; Hallak JEC; Zuardi AW; Crippa JA; de Alencar NMN; Lima-Júnior RCP; Vale ML
    Neurotox Res; 2021 Dec; 39(6):1782-1799. PubMed ID: 34792764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences.
    Noya-Riobó MV; Miguel CÁ; Soriano DB; Brumovsky PR; Villar MJ; Coronel MF
    Exp Neurol; 2023 Jan; 359():114232. PubMed ID: 36179876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin reduces c-Fos and ATF3 expression in the dorsal root ganglia and protects against oxaliplatin-induced peripheral sensory neuropathy in mice.
    Pereira AF; Pereira LMS; Silva CMP; Freitas Alves BW; Barbosa JS; Pinto FMM; Pereira AC; Silva KO; Pontes RB; Alencar NMN; Lima-Júnior RCP; Vale ML
    Neurosci Lett; 2019 Sep; 709():134378. PubMed ID: 31325582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation.
    Mulpuri Y; Marty VN; Munier JJ; Mackie K; Schmidt BL; Seltzman HH; Spigelman I
    Neuropharmacology; 2018 Sep; 139():85-97. PubMed ID: 29981335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Administration of Cannabinoid Agonists ACEA, AM1241, and CP55,940 Induce Sex-Specific Differences in Tolerance and Sex Hormone Changes in a Chemotherapy-Induced Peripheral Neuropathy.
    Barnes RC; Blanton H; Dancel CL; Castro-Piedras I; Rorabaugh BR; Morgan DJ; Guindon J
    J Pharmacol Exp Ther; 2024 Oct; 391(2):258-271. PubMed ID: 38936979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the Involvement of the Endocannabinoid System in TENS-Induced Antinociception.
    de Oliveira HU; Dos Santos RS; Malta IHS; Pinho JP; Almeida AFS; Sorgi CA; Peti APF; Xavier GS; Reis LMD; Faccioli LH; Cruz JDS; Ferreira E; Galdino G
    J Pain; 2020; 21(7-8):820-835. PubMed ID: 31785404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery.
    Rahn EJ; Deng L; Thakur GA; Vemuri K; Zvonok AM; Lai YY; Makriyannis A; Hohmann AG
    Mol Pain; 2014 Apr; 10():27. PubMed ID: 24742127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Endothelin Receptors in Peripheral Sensory Neuropathy Induced by Oxaliplatin in Mice.
    Pontes RB; Lisboa MRP; Pereira AF; Lino JA; de Oliveira FFB; de Mesquita AKV; de Freitas Alves BW; Lima-Júnior RCP; Vale ML
    Neurotox Res; 2019 Nov; 36(4):688-699. PubMed ID: 31228092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing roles of CB
    Gobira PH; Oliveira AC; Gomes JS; da Silveira VT; Asth L; Bastos JR; Batista EM; Issy AC; Okine BN; de Oliveira AC; Ribeiro FM; Del Bel EA; Aguiar DC; Finn DP; Moreira FA
    Br J Pharmacol; 2019 May; 176(10):1541-1551. PubMed ID: 30101419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative.
    Silva NR; Gomes FV; Fonseca MD; Mechoulam R; Breuer A; Cunha TM; Guimarães FS
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):369-377. PubMed ID: 28720466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of intrathecally administered AM404, an endocannabinoid reuptake inhibitor, on neuropathic pain in a rat chronic constriction injury model.
    Haranishi Y; Hara K; Terada T
    Pharmacol Rep; 2021 Jun; 73(3):820-827. PubMed ID: 33783763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.
    Sagar DR; Kelly S; Millns PJ; O'Shaughnessey CT; Kendall DA; Chapman V
    Eur J Neurosci; 2005 Jul; 22(2):371-9. PubMed ID: 16045490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain.
    Thomas A; Okine BN; Finn DP; Masocha W
    Biomed Pharmacother; 2020 Sep; 129():110456. PubMed ID: 32603895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy.
    Uhelski ML; Khasabova IA; Simone DA
    J Neurophysiol; 2015 Mar; 113(5):1501-10. PubMed ID: 25505113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
    Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG
    Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amifostine protects from the peripheral sensory neuropathy induced by oxaliplatin in mice.
    Pereira AF; Lino JA; Alves BWF; Lisboa MRP; Pontes RB; Leite CAVG; Nogueira RB; Lima-Júnior RCP; Vale ML
    Braz J Med Biol Res; 2020; 53(11):e10263. PubMed ID: 32965323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute resistance exercise induces antinociception by activation of the endocannabinoid system in rats.
    Galdino G; Romero T; Pinho da Silva JF; Aguiar D; de Paula AM; Cruz J; Parrella C; Piscitelli F; Duarte I; Di Marzo V; Perez A
    Anesth Analg; 2014 Sep; 119(3):702-715. PubMed ID: 24977916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice.
    Segat GC; Manjavachi MN; Matias DO; Passos GF; Freitas CS; Costa R; Calixto JB
    Neuropharmacology; 2017 Oct; 125():207-219. PubMed ID: 28729222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
    Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
    Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.